Video Experimental Relacionado
Updated: May 5, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 7, 2017
21.1K
Un clasificador de aprendizaje automático de conjunto para el diagnóstico de la enfermedad de Parkinson mediante
MohammadReza Hasanshahi1, Alireza Mehdizadeh2,3, Tahereh Mahmoudi4,5,6
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Scientific reports
|February 4, 2026
Resumen
Los cambios microvasculares retinianos detectados por la angiografía por tomografía de coherencia óptica (OCTA) son prometedores como biomarcadores no invasivos para la detección temprana de Parkinson
Área de la Ciencia:
- Oftalmología
- Neurología
- Imágenes Médicas
Sus antecedentes:
- El diagnóstico de la enfermedad de Parkinson (EP) es un desafío debido a la falta de biomarcadores tempranos.
- Las alteraciones microvasculares retinianas detectadas mediante OCTA están surgiendo como posibles biomarcadores no invasivos de la EP.
- Las herramientas objetivas y no invasivas son cruciales para la detección e intervención temprana de la EP.
Objetivo del estudio:
- Investigar la utilidad de las características vasculares retinianas derivadas de OCTA para la clasificación de la enfermedad de Parkinson.
- Desarrollar y validar un modelo de aprendizaje automático para la detección de EP utilizando datos de imágenes retinianas.
Principales métodos:
- Análisis retrospectivo de imágenes OCTA de 53 pacientes con EP y 39 controles sanos.
- Segmentación de complejos vasculares superficiales y profundos para extraer 22 características cuantitativas.
- Aplicación de un marco de selección de características multietapa y modelos de aprendizaje automático de conjunto (XGBoost, Random Forest, KNN).
Principales resultados:
- Un modelo de conjunto logró una precisión del 74,28%, una sensibilidad del 90%, una especificidad del 53,33% y un AUC de 0,75 en un conjunto de prueba independiente.
- Las características clave incluyeron descriptores morfológicos (factor de forma, convexidad, solidez, redondez) y densidad vascular (VAD, VSD).
- Se desarrolló una interfaz gráfica fácil de usar (PDAI) para la aplicación clínica.
Conclusiones:
- El análisis vascular retiniano basado en OCTA ofrece un enfoque no invasivo prometedor para la clasificación y el cribado de la enfermedad de Parkinson.
- El marco de IA desarrollado apoya la detección temprana de la EP y requiere una mayor validación en estudios multicéntricos más amplios.
Palabras clave:
aprendizaje de conjuntoaprendizaje automáticoangiografía por tomografía de coherencia óptica (OCTA)enfermedad de ParkinsonMás Videos Relacionados
Videos de Conceptos Relacionados
Computed Tomography
7.6K
Tomography refers to imaging by sections. Computed tomography (CT) is a non-invasive imaging technique that uses computers to analyze several cross-sectional X-rays to reveal minute details about structures in the body.
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
7.6K
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

